pd 98059 has been researched along with Venous Insufficiency in 1 studies
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one: inhibits MAP kinase kinase (MEK) activity, p42 MAPK and p44 MAPK; structure in first source
2-(2-amino-3-methoxyphenyl)chromen-4-one : A member of the class of monomethoxyflavones that is 3'-methoxyflavone bearing an additional amino substituent at position 2'.
Venous Insufficiency: Impaired venous blood flow or venous return (venous stasis), usually caused by inadequate venous valves. Venous insufficiency often occurs in the legs, and is associated with EDEMA and sometimes with VENOUS STASIS ULCERS at the ankle.
Excerpt | Relevance | Reference |
---|---|---|
" All experimental conditions were determined by dose-response and time-course experiments." | 1.35 | Regulation of matrix contraction in chronic venous disease. ( Durán, WN; Lal, BK; Ohara, N; Pappas, PJ; Saito, S; Zapiach, L, 2009) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Pappas, PJ | 1 |
Lal, BK | 1 |
Ohara, N | 1 |
Saito, S | 1 |
Zapiach, L | 1 |
Durán, WN | 1 |
1 other study available for pd 98059 and Venous Insufficiency
Article | Year |
---|---|
Regulation of matrix contraction in chronic venous disease.
Topics: Actins; Case-Control Studies; Cells, Cultured; Chronic Disease; Collagen; Dose-Response Relationship | 2009 |